SINGLE LUMEN OVUM PICK-UP NEEDLE K-OSN-1733-R-B-90

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 08 report with the FDA on 2011-09-21 for SINGLE LUMEN OVUM PICK-UP NEEDLE K-OSN-1733-R-B-90 manufactured by William Cook Australia.

Event Text Entries

[2198378] Initial information received: excessive amount of postoperative bleeding that required draining. The treatment had not changed nor the medication; the only thing they can attribute it to is the needle. No blood transfusion has taken place as of yet. Anywhere from 200 cc to 1500 cc of liquid requiring draining. The fluid is a mixture of blood and other secretions. Additional details received: six patients returned to (b)(6) clinic for follow-up appointments post transvaginal oocyte aspiration (between 14-37 eggs were collected) complaining of abdominal pain/fullness, and in some cases nausea/vomiting and increased pulse. Abdominal ultrasound was performed. If the patient was symptomatic and/or free fluid was observed in the pelvic/abdominal cavity, the patient was brought back for transvaginal aspiration of the fluid. After surgery, the patients were given iv fluids as well as iv albumin and medicated for pain and nausea. Patients were closely monitored after fluid drain. The initial information received indicated a date of event of (b)(6) 2011. However, as six patients are involved, it is unknown over what period of time this occurred.
Patient Sequence No: 1, Text Type: D, B5


[9349007] Twenty-one unused needles from the same lot number were returned. Two were inspected with a microscope and had no obvious signs of degeneration of the tip or side bevels. There was no evidence of "dulling" of the cutting edges or deformation at the very tip of the needle where the facets meet. There was no evidence of any imperfections on the surface of the beveled tips. The work order is complete and correct and there is no evidence that the products were not manufactured to specification. There are a number of quality checks in place during manufacture that would most likely identify a blunt or damaged tip, and throughout manufacture the tip is covered with a tip protector or needle protector. The needles are also packed and shipped with a needle protector. The information reported by the complainant is suggestive of a known risk associated with an ovum aspiration procedure and possible effects of ovarian hyper stimulation syndrome, i. E. Bleeding and accumulation of fluid in the abdominal cavity following the procedure. It is not uncommon for fluid to accumulate and require drainage following this type of procedure. (b)(4). The manufacturer will continue to monitor for any emerging trends. No corrective action deemed necessary.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9680654-2011-00001
MDR Report Key2265459
Report Source08
Date Received2011-09-21
Date of Report2011-09-20
Date of Event2011-08-23
Date Mfgr Received2011-08-25
Device Manufacturer Date2011-06-11
Date Added to Maude2011-09-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactBERNEEN GARDINER, MANAGER
Manufacturer Street95 BRANDL STREET
Manufacturer CityEIGHT MILE PLAINS, BRISBANE 4113
Manufacturer CountryAS
Manufacturer Postal4113
Manufacturer Phone33401872
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSINGLE LUMEN OVUM PICK-UP NEEDLE
Generic NameMQE NEEDLE, ASSISTED REPRODUCTION - OVUM PICK-UP ASPIRATION NEEDLE
Product CodeMQE
Date Received2011-09-21
Returned To Mfg2011-09-14
Model NumberNA
Catalog NumberK-OSN-1733-R-B-90
Lot NumberA879975
Device Expiration Date2014-06-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerWILLIAM COOK AUSTRALIA
Manufacturer AddressBRISBANE AS


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2011-09-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.